Published in Gut on January 01, 1996
Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole. Gut (1999) 1.50
Cell proliferation in type C gastritis affecting the intact stomach. J Clin Pathol (2000) 0.81
Duodenogastric reflux following biliary reconstruction after excision of choledochal cyst. Pediatr Surg Int (2005) 0.79
Inhibiting acid and Helicobacter pylori? Gut (1997) 0.77
Cigarette smoking promotes atrophic gastritis in Helicobacter pylori-positive subjects. Dig Dis Sci (2002) 0.77
Helicobacter pylori and duodenogastric reflux. Gut (1996) 0.75
Reproducibility and intragastric variation of duodenogastric reflux using ambulatory gastric bilirubin monitoring. Dig Dis Sci (2001) 0.75
Gastric mucosa lesions induced by duodenogastric reflux increase penetration of N-[3H]-methyl-N-nitro-N-nitrosoguanidine into corpus mucosa of rats. Dig Dis Sci (2002) 0.75
Inhibitory potency of twice-a-day omeprazole on gastric acidity is enhanced by eradication of H. pylori in duodenal ulcer patients. Dig Dis Sci (2003) 0.75
Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med (1991) 23.89
Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet (1989) 9.76
Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol (1987) 7.09
Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis (1990) 6.90
Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med (1989) 5.78
Rapid urease test in the management of Campylobacter pyloridis-associated gastritis. Am J Gastroenterol (1987) 4.70
Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology (1992) 4.63
One week eradication regimen for Helicobacter pylori. Lancet (1991) 4.50
Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet (1994) 4.07
Increased reflux of bile into the stomach in patients with gastric ulcer. Gastroenterology (1969) 2.86
Reflux gastritis: distinct histopathological entity? J Clin Pathol (1986) 2.73
Campylobacter like organisms and reflux gastritis. J Clin Pathol (1986) 1.99
Detection of Campylobacter pylori by the biopsy urease test: an assessment in 1445 patients. Gut (1989) 1.91
Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet (1992) 1.88
Bile reflux and intestinal metaplasia in gastric mucosa. J Clin Pathol (1993) 1.60
The effect of bile acids on the growth and adherence of Helicobacter pylori. Aliment Pharmacol Ther (1991) 1.56
Campylobacter pylori, acid, and bile. J Clin Pathol (1987) 1.51
Lysolecithin: a factor in the pathogenesis of gastric ulceration? Gut (1974) 1.47
Effect of Roux-en-Y biliary diversion on Campylobacter pylori. Gastroenterology (1989) 1.14
Prospective comparative study of the influence of postoperative bile reflux on gastric mucosal histology and Campylobacter pylori infection. Gut (1989) 1.11
Intragastric bile acids and histological changes in gastric mucosa. Br J Surg (1986) 1.06
Clinical value of endoscopy and histology in the diagnosis of duodenogastric reflux disease. Surgery (1992) 1.00
Sensitivity of Helicobacter pylori to different bile salts. Eur J Clin Microbiol Infect Dis (1991) 0.96
One week's anti-Helicobacter pylori treatment for duodenal ulcer. Gut (1994) 0.95
Retrospective study of Campylobacter-like organisms in patients undergoing partial gastrectomy. J Clin Pathol (1988) 0.95
Role of Helicobacter pylori infection and duodenogastric reflux in the pathogenesis of alkaline reflux gastritis after gastric operations. Surg Gynecol Obstet (1993) 0.93
Pyloric reflux and G-cell hyperfunction. Lancet (1980) 0.81
A simple method for the quantification of biliary reflux. Scand J Gastroenterol (1980) 0.81
Reversibility of pyloric sphincter dysfunction in gastric ulcer. Gastroenterology (1975) 0.80
[Digestive cancer mortality in a Mediterranean urban area (Barcelona, 1983-1987)]. Rev Esp Enferm Dig (1990) 0.79
Biochemical and histopathological aspects in duodenogastric reflux gastritis patients with or without prior cholecystectomy. Acta Gastroenterol Belg (1993) 0.77
Acquisition of competence in colonoscopy: the learning curve of trainees. Endoscopy (1999) 2.22
Effect of forceps size and mode of orientation on endoscopic small bowel biopsy evaluation. Gastrointest Endosc (1994) 1.54
Selection of patients for successful maintenance treatment of esophagitis with low-dose omeprazole: use of 24-hour gastric pH monitoring. Am J Gastroenterol (2000) 1.40
Antiphospholipid syndrome: clinical and therapeutic aspects. Lupus (1994) 1.39
Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity. Metabolism (1999) 1.22
Thyroid hormone excess and glucose intolerance. Exp Clin Endocrinol Diabetes (2001) 1.18
Glucose transporter expression on the plasma membrane of resting and activated white blood cells. Eur J Clin Invest (2007) 1.16
A reappraisal of the utility of somatostatin receptor scintigraphy in patients with ectopic adrenocorticotropin Cushing's syndrome. J Clin Endocrinol Metab (2003) 1.12
Comparison of docetaxel and docetaxel-irinotecan combination as second-line chemotherapy in advanced non-small-cell lung cancer: a randomized phase II trial. Ann Oncol (2005) 1.01
Factors that may affect treatment outcome of triple Helicobacter pylori eradication therapy with omeprazole, amoxicillin, and clarithromycin. Dig Dis Sci (2000) 0.97
Pancreatic tuberculosis in non-immunocompromised patients: reports of two cases, and a literature review. Eur J Gastroenterol Hepatol (1998) 0.96
Adrenaloma: a call for more aggressive management. World J Surg (1996) 0.96
TNF-alpha, TGF-beta1, IL-10, IL-6, gene polymorphisms in latent autoimmune diabetes of adults (LADA) and type 2 diabetes mellitus. J Clin Immunol (2004) 0.92
Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS): treatment outcome, relapses, prognostic factors. A single-center experience of 48 cases. Ann Hematol (2000) 0.92
Honey may have a laxative effect on normal subjects because of incomplete fructose absorption. Am J Clin Nutr (1995) 0.90
Management and outcome of severe diabetic foot infections. Exp Clin Endocrinol Diabetes (1998) 0.90
Differential effects of high-fat and high-carbohydrate content isoenergetic meals on plasma active ghrelin concentrations in lean and obese women. Horm Metab Res (2004) 0.90
Intracellular IFN-gamma production and IL-12 serum levels in latent autoimmune diabetes of adults (LADA) and in type 2 diabetes. J Interferon Cytokine Res (2004) 0.90
Effectiveness of two quadruple, tetracycline- or clarithromycin-containing, second-line, Helicobacter pylori eradication therapies. Aliment Pharmacol Ther (2002) 0.89
The association between CagA status and the development of esophagitis after the eradication of Helicobacter pylori. Am J Med (2001) 0.89
Does acromegaly really predispose to an increased prevalence of gastrointestinal tumours? Clin Endocrinol (Oxf) (1994) 0.89
Common cytogenetic findings in gastric cancer. Cancer Genet Cytogenet (1987) 0.88
Dose-dependent effects of recombinant human interleukin-6 on the pituitary-testicular axis. J Interferon Cytokine Res (1999) 0.88
Splenectomy in patients with malignant non-Hodgkin's lymphoma. Eur J Haematol (2000) 0.88
Choledochocele, an overlooked diagnosis: report of 15 cases and review of 56 published reports from 1984 to 1992. Endoscopy (1995) 0.88
Reproducible lactulose hydrogen breath test as a measure of mouth-to-cecum transit time. Dig Dis Sci (1989) 0.87
Percutaneous endoscopic gastrostomy: adequacy and quality of information given to decision makers. Dig Dis (2002) 0.87
Differential effects of high-fat and high-carbohydrate isoenergetic meals on cardiac autonomic nervous system activity in lean and obese women. Metabolism (2003) 0.87
Endoscopic sclerotherapy plus propranolol versus propranolol alone in the primary prevention of bleeding in high risk cirrhotic patients with esophageal varices: a prospective multicenter randomized trial. Gastrointest Endosc (2000) 0.86
Coincidental malabsorption of lactose, fructose, and sorbitol ingested at low doses is not common in normal adults. Dig Dis Sci (2000) 0.86
Visfatin, TNF-alpha and IL-6 mRNA expression is increased in mononuclear cells from type 2 diabetic women. Horm Metab Res (2007) 0.86
Expression of the long and short leptin receptor isoforms in peripheral blood mononuclear cells: implications for leptin's actions. Metabolism (2000) 0.85
Blood lipids in Greek adolescents and their relation to diet, obesity, and socioeconomic factors. Ann Epidemiol (1995) 0.85
Long-term effectiveness of a new alpha-glucosidase inhibitor (BAY m1099-miglitol) in insulin-treated type 2 diabetes mellitus. Diabet Med (1998) 0.85
Bone mineral density of both genders in Type 1 diabetes according to bone composition. J Diabetes Complications (2006) 0.84
Effects of adiponectin in TNF-α, IL-6, and IL-10 cytokine production from coronary artery disease macrophages. Horm Metab Res (2011) 0.83
Skeletal muscle insulin resistance in morbid obesity: the role of interleukin-6 and leptin. Exp Clin Endocrinol Diabetes (2011) 0.83
Pancreatic duct width: its significance as a diagnostic criterion for pancreatic disease. Hepatogastroenterology (1993) 0.82
Complex carbohydrate malabsorption in exocrine pancreatic insufficiency. Gut (1993) 0.82
Bone mineral density of vertebrae, proximal femur and os calcis in normal Greek subjects as assessed by dual-energy X-ray absorptiometry: comparison with other populations. Eur J Clin Invest (1997) 0.81
Effects of alpha-glucosidase inhibitors on mouth to caecum transit time in humans. Gut (1992) 0.81
Rates of lipid fluxes in adipose tissue in vivo after a mixed meal in morbid obesity. Int J Obes (Lond) (2010) 0.81
TNFalpha and leptin inhibit basal and glucose-stimulated insulin secretion and gene transcription in the HIT-T15 pancreatic cells. Int J Obes Relat Metab Disord (2001) 0.81
Relationship of Helicobacter pylori CagA(+) status to gastric juice vitamin C levels. Eur J Clin Invest (1999) 0.81
Sucralfate enemas in the treatment of chronic postradiation proctitis. Am J Gastroenterol (1989) 0.81
Diabetes and premature menopause: is their co-existence detrimental to the skeleton? Eur J Endocrinol (2005) 0.80
Early vascular lesions in subjects with metabolic syndrome and prediabetes. Int Angiol (2006) 0.80
Thyroid hormone excess increases basal and insulin-stimulated recruitment of GLUT3 glucose transporters on cell surface. Horm Metab Res (2005) 0.80
Prospective evaluation of a whole-blood antibody test (FlexPack HP) for in-office diagnosis of Helicobacter pylori infection in untreated patients. Eur J Gastroenterol Hepatol (2000) 0.80
Does subclinical hypercortisolism adversely affect the bone mineral density of patients with adrenal incidentalomas? Clin Endocrinol (Oxf) (2003) 0.80
Predictive factors and prevalence of follicular gastritis in adults with peptic ulcer and nonulcer dyspepsia. Dig Dis Sci (1999) 0.79
Restoration of early insulin secretion after a meal in type 2 diabetes: effects on lipid and glucose metabolism. Eur J Clin Invest (2004) 0.79
Improved glycaemic control with miglitol in inadequately-controlled type 2 diabetics. Diabetes Res Clin Pract (2001) 0.79
Anemia due to coadministration of renin-angiotensin-system inhibitors and PPARγ agonists in uncomplicated diabetic patients. Exp Clin Endocrinol Diabetes (2012) 0.79
Oxytocin and psychological factors affecting type 2 diabetes mellitus. Exp Diabetes Res (2012) 0.79
Evaluation of a single-step serological assay for laboratory diagnosis of Helicobacter pylori infection. Eur J Clin Microbiol Infect Dis (2002) 0.78
Primary prophylaxis of variceal bleeding in cirrhotics unable to take beta-blockers: a randomized trial of ligation. Aliment Pharmacol Ther (2005) 0.78
Tuberculous esophagitis. Report of a case and review of modern approaches to diagnosis and treatment. Hepatogastroenterology (1995) 0.78
Honey, fructose absorption, and the laxative effect. Nutrition (1999) 0.78
Efficacy of intravenous immunoglobulin in the treatment of thrombotic thrombocytopaenic purpura. A study of 44 cases. Acta Haematol (2001) 0.78
Impaired erythrocyte deformability precedes vascular changes in experimental diabetes mellitus. Horm Metab Res (2004) 0.78
Effect of diabetes on porphyric attacks. Br Med J (Clin Res Ed) (1987) 0.78
The desmopressin and combined CRH-desmopressin tests in the differential diagnosis of ACTH-dependent Cushing's syndrome: constraints imposed by the expression of V2 vasopressin receptors in tumors with ectopic ACTH secretion. J Clin Endocrinol Metab (2002) 0.77
Red blood cell deformability index in diabetic retinopathy. Horm Metab Res (1987) 0.77
The role of colonoscopy in the differential diagnosis of acute, severe hemorrhagic colitis. Endoscopy (1995) 0.77
Effectiveness of acid suppression in preventing gastroesophageal reflux disease (GERD) after successful treatment of Helicobacter pylori infection. Dig Dis Sci (2001) 0.77
Adrenal incidentalomas and cardiometabolic morbidity: an emerging association with serious clinical implications. J Intern Med (2010) 0.77
The role of diabetic neuropathy and high plantar pressures in the pathogenesis of foot ulceration. Horm Metab Res (1996) 0.76
Effect of hyperthyroidism on clearance and secretion of glucagon in man. Exp Clin Endocrinol Diabetes (2011) 0.76
Efficacy of deoxycholate amphotericin B and unilamellar liposomal amphotericin B in prophylaxis of experimental Aspergillus fumigatus endocarditis. Mayo Clin Proc (1997) 0.75
Sedation for upper gastrointestinal endoscopy: time for reappraisal? Gastrointest Endosc (1990) 0.75
Cytogenetic data as a prognostic factor in multiple myeloma patients: involvement of 1p12 region an adverse prognostic factor. Anticancer Res (2005) 0.75
A simple test for predicting patients' tolerance of upper gastrointestinal endoscopy. Endoscopy (1997) 0.75
Acute nateglinide administration in subjects with type 2 diabetes: effects on postprandial metabolism, coagulation, and fibrinolysis. Nutr Metab Cardiovasc Dis (2005) 0.75
The type and time of menopause as decisive factors for bone mass changes. Eur J Clin Invest (1999) 0.75
Left systolic atrioventricular plane displacement in the assessment of myocardial viability in patients with previous myocardial infarction. Acta Cardiol (1995) 0.75
Performance of two immunosorbent assay kits for the detection of serum immunoglobulin G to Helicobacter pylori in untreated greek patients. Scand J Gastroenterol (2002) 0.75
Diabetes in postmenopause: different influence on bone mass according to age and disease duration. Exp Clin Endocrinol Diabetes (2008) 0.75
The effects of the somatostatin analogue SMS 201-995 on carbohydrate homeostasis of insulin-dependent diabetics as assessed by the artificial endocrine pancreas. Diabetes Res Clin Pract (1988) 0.75
Iron metabolism and red cell survival in uremic patients. Acta Haematol (1972) 0.75
Omeprazole induces a long-term clinical remission of protein-losing gastropathy of Ménétrier's disease. Eur J Gastroenterol Hepatol (1997) 0.75
The clinical need for sphincter of Oddi manometry in gastrointestinal endoscopy units. Endoscopy (1993) 0.75
A gastrointestinal endoscopy service in Greece. Gastrointest Endosc (1987) 0.75
Effect of abnormal atmospheric pressure conditions upon mouse liver delta-aminolevulinic acid synthetase activity. Enzyme (1985) 0.75
Efficacy of a new needleless insulin delivery system monitoring of blood glucose fluctuations and free insulin levels. Int J Artif Organs (1989) 0.75
Therapeutic effect of glibenclamide in a fixed combination with metformin or phenformin in NIDDM patients. Horm Metab Res (1996) 0.75
Comparative in vitro and in vivo efficacy of roxithromycin and erythromycin against a strain of methicillin-susceptible Staphylococcus epidermidis. Diagn Microbiol Infect Dis (1998) 0.75
The importance of adipose tissue in diabetes pathophysiology and treatment. Horm Metab Res (2007) 0.75
A three-day octreotide-containing helicobacter pylori eradication therapy for cure of peptic ulcers. Hepatogastroenterology (1998) 0.75
Comparative study of the therapeutic effects of glibenclamide or the fixed combination of glibenclamide-phenformin with those of gliclazide or chlorpropamide. Acta Diabetol Lat (1990) 0.75
The antidiabetic action of somatostatin-28 as assessed by the artificial endocrine pancreas: greater potency than somatostatin-14. Horm Metab Res (1987) 0.75
Metabolic syndrome and prediabetes identify overlapping but not identical populations. Exp Clin Endocrinol Diabetes (2006) 0.75
Differences between somatostatin-28 and somatostatin-14 with respect to their biological effects in healthy humans and acromegalics. Clin Physiol Biochem (1986) 0.75
Cytogenetic findings in a Fanconi anemia patient with AML. Cancer Genet Cytogenet (1996) 0.75
Macrovascular disease of coronaries and cerebral arteries in streptozotocin-induced diabetic rats. A controlled, comparative study. Exp Clin Endocrinol Diabetes (1998) 0.75